Abstract | PURPOSE: To report our results of medical management of myopia, and add these to the prior literature supporting this practice. METHOD: Retrospective review of the medical records of 35 patient-subjects offered this treatment with adequate followup over a five year period. Treatment consisted of prescription of photochromic gray extra lenses incorporating full myopic correction with a +3.00 bifocal addition, and atropine 1% ophthalmic drops, one in each eye, each night at bedtime. Compliance was monitored based upon mydriasis and cycloplegia. RESULTS: The mean change in refractive error per year was +0.07 diopters for the always compliant group, that is, a decrease in the amount of myopia; -0.18 diopters per year for the sometimes compliant group; and -0.17 diopters for the never compliant group, an increase in the degree of myopia. Statistical comparison of our always compliant group with each of the other two groups using the t-test, yielded a P value of P<.10 in each case, considered to be "medically/clinically significant". Comparison of the mean annual change in refractive error of our always compliant group (+0.07 D/yr) with the mean annual change in re-fractive error in the general population aged 8-15 years (-0.24 D/yr) shows an absolute difference of 0.31 D/yr. This difference is "statistically significant" (t-test) with a P <.02. CONCLUSION:
|
Authors | P E Romano, J P Donovan |
Journal | Binocular vision & strabismus quarterly
(Binocul Vis Strabismus Q)
Vol. 15
Issue 3
Pg. 257-60
( 2000)
ISSN: 1088-6281 [Print] United States |
PMID | 10960233
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Mydriatics
- Ophthalmic Solutions
- Atropine
|
Topics |
- Adolescent
- Atropine
(administration & dosage)
- Child
- Child, Preschool
- Disease Progression
- Eyeglasses
- Female
- Humans
- Male
- Mydriatics
(administration & dosage)
- Myopia
(therapy)
- Ophthalmic Solutions
- Refraction, Ocular
- Retrospective Studies
- Treatment Outcome
|